IolT2 Transporter Variant for Higher L-Glutamic Acid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for enhancing L-glutamic acid production in microorganisms like Corynebacterium sp. are limited by the lack of effective genetic modifications in proteins involved in the biosynthetic pathway, particularly transport proteins such as myo-inositol facilitator IolT2, which hinders efficient productivity.
Innovation Solution
Introduction of a myo-inositol facilitator IolT2 variant with a specific amino acid substitution, such as lysine for glutamic acid at position 424, to enhance the activity of the IolT2 protein, combined with a recombinant vector and transformant to increase L-glutamic acid production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional wild-type strains or conventional mutant strains are used for L-glutamic acid production, then the production process is relatively simple, but the productivity and metabolic efficiency are insufficient
Solution Approach 1:
The patent applies parameter changes by substituting specific amino acids at defined positions in the IolT2 protein sequence (e.g., E424K substitution). This precise modification of protein parameters enhances myo-inositol transport activity and metabolic efficiency, thereby increasing L-glutamic acid productivity without requiring complex genetic engineering approaches
Solution Approach 2:
The patent implements local quality by making targeted amino acid substitutions at specific positions (e.g., position 424) within the IolT2 protein rather than modifying the entire protein or using global mutagenesis. This localized modification approach optimizes specific functional regions of the protein to enhance transport activity while maintaining overall protein structure and function
2Productivity
If multiple proteins and genes involved in L-glutamic acid biosynthesis are modified, then productivity may increase, but the research and development time and complexity increase significantly
Solution Approach 1:
The patent extracts and focuses on a single key limiting factor - the IolT2 myo-inositol facilitator protein - rather than attempting to modify multiple proteins and genes simultaneously. By identifying and optimizing this specific transport protein, the patent achieves significant productivity improvements with minimal research and development time investment
Solution Approach 2:
Instead of following the conventional approach of modifying enzymes and metabolic pathway genes to improve L-glutamic acid production, the patent inverts the strategy by focusing on modifying a transport protein (IolT2) that facilitates substrate uptake. This reverse approach reveals that enhancing nutrient transport can be more effective and time-efficient than modifying downstream metabolic enzymes
Data Source
Figure 1
AI summary
The present invention relates to a Corynebacterium sp. microorganism producing L-glutamic acid and a method of producing L-glutamic acid using the same, and more specifically, to a myo-inositol facilitator IolT2 variant involved in the L-glutamic acid biosynthetic pathway, a polynucleotide, and a transformant, as well as a method of producing L-glutamic acid using the same. The myo-inositol facilitator IolT2 variant according to the present invention is obtained by substituting one or more amino acids in the amino acid sequence constituting myo-inositol facilitator IolT2 to change the activity of the protein, and a recombinant microorganism comprising the myo-inositol facilitator IolT2 variant is capable of efficiently producing L-glutamic acid.